Cosmo Pharmaceuticals announces agenda of the R&D Day 2019
Dublin - April 24, 2019 - Cosmo Pharmaceuticals NV (SIX: COPN) today announced the agenda of the May 8, 2019, R&D Day in Zurich. Cosmo's management will present to its shareholders, analysts and the financial press a comprehensive update on their products and their strategy.
The meeting will take place on 8 May 2019, at the Zunfthaus zur Saffran, Limmatquai 54, 8001 Zurich, starting at 15:00 h, with the following agenda:
15.00 h - Welcome and introduction
15:10 h - Company perspectives and strategy
15:30 h - Artificial Intelligence in colonoscopy: our new device in play
16:00 h - Aemcolo: a novel marketing approach
16.40 h - New products in the pipeline
17:00 h - Wrap-up and Q&A
18.00 h - Drinks and stand-up dinner
Investors, analysts and media representatives interested in attending can register until 3 May 2019, by sending an e-mail to cosmo@irf-reputation.ch.
The event will be webcast, a replay will be available on the website: http://www.cosmopharmaceuticals.com/investor-relations/presentations/2019
Provider | Channel | Contact | ||
---|---|---|---|---|
EQS Group Ltd., Switzerland switzerland.eqs.com |
newsbox.ch www.newsbox.ch |
Provider/Channel related enquiries cs.switzerland@eqs.com +41 41 763 00 50 |